April 19, 2024
Stocks & Bonds
[STOCK WATCH] Medy-Tox rises 2.56%
[THE INVESTOR] As of Jan. 2 10:40 A.M., Medy-Tox increased 2.56%, compared with yesterday, to 497,300 won. It had increased 5.36% through the past month. Standard deviation, which indicates volatility of stock, records 2.7% on the same period over one month.
Compared with its close competitors within the same industry, KOSDAQ, as the monthly volatility was lower than that of its peer group, the earnings rate of Medy-Tox over one month was comparatively low. Over the recent month, the Return On Risk, the return on investment with consideration about risk, was 1.9. Though its volatility was not so high, the Return On Risk was low on the whole with a poor earnings rate. Moreover, compared with the KOSDAQ industry, the Return On Risk is below the industrial mean, 2.7, and thus it is hard to say that the industrial comparison performance was positive.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.
Compared with its close competitors within the same industry, KOSDAQ, as the monthly volatility was lower than that of its peer group, the earnings rate of Medy-Tox over one month was comparatively low. Over the recent month, the Return On Risk, the return on investment with consideration about risk, was 1.9. Though its volatility was not so high, the Return On Risk was low on the whole with a poor earnings rate. Moreover, compared with the KOSDAQ industry, the Return On Risk is below the industrial mean, 2.7, and thus it is hard to say that the industrial comparison performance was positive.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.
